Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Sep 2023. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5259488012 | Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
5259489016 | Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
5259796018 | Adult B and BA.4/BA.5 lineage SARS-CoV-2 bivalent mRNA only vaccine product | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
5261870011 | Adult SARS-CoV-2 original strain spike protein and omicron sub-variant BA.4/BA.5 lineage spike protein mRNA vaccine | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
671181000274117 | mRNA-Impfstoff gegen COVID-19 der Sublinie B und BA.4/BA.5 für Erwachsene | de | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | Plays role | Active immunity stimulant role (role) | true | Inferred relationship | Some | ||
Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | This attribute represents the target population in which a product is intended to be used. | Adult population (qualifier value) | true | Inferred relationship | Some | ||
Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Severe acute respiratory syndrome coronavirus 2 mRNA encoding BA.4/BA.5 lineage spike protein | true | Inferred relationship | Some | 2 | |
Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Severe acute respiratory syndrome coronavirus 2 mRNA encoding B lineage spike protein | true | Inferred relationship | Some | 1 | |
Adult vaccine product containing only severe acute respiratory syndrome coronavirus 2 encoding B lineage spike protein and BA.4/BA.5 lineage spike protein messenger ribonucleic acid (medicinal product) | Is a | SARS-CoV-2 mRNA vaccine | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets